Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Theravance Biopharma, Inc. | Director | Ordinary Shares | 80.6K | $696K | $8.64 | May 8, 2024 | Direct |
Certara, Inc. | Director | Common Stock | 23K | $409K | $17.77 | May 21, 2024 | Direct |
Certara, Inc. | Director | Restricted Stock Units | 11.9K | $212K | $17.77 | May 21, 2024 | Direct |
Theravance Biopharma, Inc. | Director | Share Option (Right to Buy) | 23.6K | May 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CERT | Certara, Inc. | May 21, 2024 | 3 | $0 | 4 | May 23, 2024 | Director |
TBPH | Theravance Biopharma, Inc. | May 8, 2024 | 2 | $0 | 4 | May 10, 2024 | Director |
CERT | Certara, Inc. | Aug 21, 2023 | 2 | $79.1K | 4 | Aug 23, 2023 | Director |
CERT | Certara, Inc. | May 23, 2023 | 3 | $0 | 4 | May 25, 2023 | Director |
TBPH | Theravance Biopharma, Inc. | May 2, 2023 | 2 | $0 | 4 | May 4, 2023 | Director |
CERT | Certara, Inc. | Jul 13, 2022 | 1 | $0 | 4 | Jul 15, 2022 | Director |
CERT | Certara, Inc. | Jul 11, 2022 | 0 | $0 | 3 | Jul 15, 2022 | Director |
TBPH | Theravance Biopharma, Inc. | Apr 26, 2022 | 2 | $0 | 4 | Apr 28, 2022 | Director |